Jacobs and Pfizer Provide Sterile Drug Product Manufacturing Technology to Emerging Markets
February 04 2014 - 7:45AM
Business Wire
Jacobs Engineering Group Inc. (NYSE:JEC) announced today a
collaboration with Pfizer Inc. on a modular process system to
address the rapidly changing requirements of localized
pharmaceutical manufacturing in emerging market countries.
The collaboration brings together Pfizer’s aseptic drug product
process expertise and Jacobs’ capabilities in modular engineering,
fabrication, and testing to create a Rapid Deployment Module (RDM)
that integrates modular equipment, fully-automated control systems
and single-use technology for bags, mixers, sterile connectors,
manifolds and filters. The portable system is scalable for
different batch sizes, adaptable for various products and can be
rapidly deployed, and offers significant cost and schedule
advantages compared to large manufacturing facilities with fixed
equipment and limited flexibility.
In making the announcement, Jacobs Group Vice President Chris
Nagel stated, “We are very pleased to be collaborating with Pfizer
on this initiative to help meet the diverse medical needs of
patients in emerging markets around the world. Our system uses
off-the-shelf technology that requires minimal space and utilities.
It is a process that can be replicated globally and offers a number
of potential benefits such as reduced equipment, validation and
operating costs; and compressed production cycles and training
requirements.”
Kevin Nepveux, Vice President of Pfizer’s Global Technical
Services, remarked, “The Rapid Deployment Module we developed with
Jacobs has improved the quality and speed of our technology
transfers by making our process more robust through specific
engineering solutions. This system embodies the innovation culture
that we strive for.”
The production systems are currently in their final stages of
validation at a number of local pharmaceutical manufacturing sites
around the world.
Jacobs is one of the world's largest and most diverse providers
of technical professional and construction services.
Statements made in this release that are not based on historical
fact are forward-looking statements. We base these forward-looking
statements on management’s current estimates and expectations as
well as currently available competitive, financial and economic
data. Forward-looking statements, however, are inherently
uncertain. There are a variety of factors that could cause business
results to differ materially from our forward-looking
statements. For a description of some of the factors which may
occur that could cause actual results to differ from our
forward-looking statements please refer to our 2013 Form 10-K, and
in particular the discussions contained under Items 1 - Business,
1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's
Discussion and Analysis of Financial Condition and Results of
Operations. We do not undertake to update any forward-looking
statements made herein.
Jacobs Engineering Group Inc.Michelle Jones, 626.578.6968
Jacobs Engineering (NYSE:JEC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Jacobs Engineering (NYSE:JEC)
Historical Stock Chart
From Jul 2023 to Jul 2024